Through the pilot, stakeholders can secure access to feedback on their NAM from non-clinical experts.
BELLEVUE, Washington, Aug. 05, 2026 (GLOBE NEWSWIRE) -- To further support CDM Smith's Research & Development (R&D) Program and innovation, the firm has expanded its Research and Testing Laboratory ...
On Friday, the Food and Drug Administration announced a new pilot prioritization program for the review of abbreviated new drug applications that aims to spur and reward investment in U.S. drug ...